Lurbinectedin Superior to Topotecan for Treating SCLC
In a recent publication in Lung Cancer, data from a post hoc analysis exploring the use of lurbinectedin for the treatment of SCLC demonstrated that the agent was more effective and less toxic than topotecan. Regarding the objective of this study, the …